Short chain fatty acids reduce the respiratory burst of human neutrophils in response to cystic fibrosis isolates of Staphylococcus aureus
Journal of Cystic Fibrosis · 2023-07 · 22 (4) · 756-762
DOI: 10.1016/j.jcf.2023.04.022 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cystic Fibrosis, 2023-07. Verfasst von Arthur Miller und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, College of Veterinary Medicine, The University of Georgia, Athens, GA, USA. Hauptthemen laut MEDLINE: Cystic Fibrosis, Staphylococcal Infections. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIAID NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Short chain fatty acids (SCFA) are produced by anaerobic bacteria. The most common SCFAs are acetate, propionate and butyrate. SCFAs have been implicated in several inflammatory diseases including cystic fibrosis (CF) where they are present in the airways at millimolar concentrations. Staphylococcus aureus is one of the main respiratory pathogens in CF. Polymorphonuclear neutrophil granulocytes (PMN) represent the most important immune defense the host uses against S. aureus. However, the reason why PMNs are unable to clear S. aureus in CF remains largely unclear. We hypothesized that SCFAs impair effector functions of PMNs in response to S. aureus. To test this, human PMNs were exposed to CF clinical isolates of S. aureus in vitro in the presence or absence of SCFAs and effector functions of PMNs were assessed. Our data show that SCFAs do not affect the viability of PMNs and do not stimulate the release of neutrophil extracellular traps (NET) from human PMNs. Production of reactive oxygen species (ROS), another important antimicrobial function of PMNs, on the other hand, was significantly inhibited by SCFAs in response to the bacterium. SCFAs did not compromise the ability of PMNs to kill CF isolates of S. aureus in vitro. Overall, our results provide new knowledge into the interactions between SCFAs and the immune system, and indicate that SCFAs produced by anaerobic bacteria in the CF lung could interfere with reactive oxidant production of PMNs in response to S. aureus, one of the prominent respiratory pathogens in this disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, College of Veterinary Medicine, The University of Georgia, Athens, GA, USA.
- Division of Pulmonology, Asthma, Cystic Fibrosis and Sleep, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.
- Department of Infectious Diseases, College of Veterinary Medicine, The University of Georgia, Athens, GA, USA. Electronic address: radab@uga.edu.
Förderung
- NHLBI NIH HHS
- NIAID NIH HHS
- National Institutes of Health
Zitieren
APA
Miller, A., Fantone, K. M., Tucker, S. L., Gokanapudi, N., Goldberg, J. B., & Rada, B. (2023). Short chain fatty acids reduce the respiratory burst of human neutrophils in response to cystic fibrosis isolates of Staphylococcus aureus. Journal of Cystic Fibrosis, 22(4), 756-762. https://doi.org/10.1016/j.jcf.2023.04.022
Vancouver
Miller A, Fantone KM, Tucker SL, Gokanapudi N, Goldberg JB, Rada B. Short chain fatty acids reduce the respiratory burst of human neutrophils in response to cystic fibrosis isolates of Staphylococcus aureus. Journal of Cystic Fibrosis. 2023;22(4):756-762. doi:10.1016/j.jcf.2023.04.022
BibTeX
@article{Miller2023,
author = {Miller, Arthur and Fantone, Kayla M and Tucker, Samantha L and Gokanapudi, Naveen and Goldberg, Joanna B and Rada, Balázs},
title = {Short chain fatty acids reduce the respiratory burst of human neutrophils in response to cystic fibrosis isolates of Staphylococcus aureus},
journal = {Journal of Cystic Fibrosis},
year = {2023},
volume = {22},
number = {4},
pages = {756--762},
doi = {10.1016/j.jcf.2023.04.022}
}
EUVIMED